Surface antigen expression in chronic lymphocytic leukemia: Clustering analysis, interrelationships and effects of chromosomal abnormalities

Leukemia

Volumn 16, Issue 2, 2002, Pages 178-185

  Hulkkonen, J ^a   Vilpo, L ^a   Hurme, M ^a   Vilpo, J ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Chromosome; Chronic lymphocytic leukemia; Cluster analysis; Cluster of differentiation

Indexed keywords

B7 ANTIGEN; CD14 ANTIGEN; CD19 ANTIGEN; CD20 ANTIGEN; CD22 ANTIGEN; CD23 ANTIGEN; CD27 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD45 ANTIGEN; CD5 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; FAS ANTIGEN; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN M; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 6 RECEPTOR; MEMBRANE ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; ATTENUATION; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME ABERRATION; CHROMOSOME ARM; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DRUG RESPONSE; FEMALE; FLOW CYTOMETRY; GENETIC DISORDER; HUMAN; HUMAN CELL; MALE; MULTIGENE FAMILY; PRIORITY JOURNAL; TRISOMY 12;

EID: 0036166593     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402363     Document Type: Article

References (40)

1. Chronic lymphocytic leukemia
2. Molecular pathogenesis of chronic lymphocytic leukemia: Factors and signaling pathways regulating cell growth and survival
3. Genomic aberrations and survival in chronic lymphocytic leukemia
4. Proposals for the classification of chronic (mature) B and T lymphoid leukemias
5. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL
6. Bone marrow histologic pattern - The best single prognostic parameter in chronic lymphocytic leukemia: A multivariate survival analysis of 329 cases
7. Chromosome aberrations in B-cell chronic lymphocytic leukemia: Reassessment based on molecular cytogenetic analyses
8. CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis
9. Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia
10. The value of scoring systems for the diagnosis of biphenotypic leukemia and mature B cell disorders
11. Non-specific binding compromises the purification yields of leukemic B cells in chronic lymphocytic leukemia: Prevention by collagen coating
12. Selective toxicity of vincristine against chronic lymphocytic leukemia cells in vitro
13. Cluster analysis and display of genome-wide expression patterns
14. Apoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells by cross-linking of surface IgM or IgD
15. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia
16. B-lymphocytes in CLL and NHL differ in the mRNA splicing pattern of the CD45 molecule
17. Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells
18. Expression and release of CD27 in human B-cell malignancies
19. Reduced expression of adhesion molecules and cell signaling receptors by chronic lymphocytic leukemia cells with 11q deletion
20. CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by upregulation of CD80 and CD86 costimulatory molecules
21. The heterogenous expression of CD80, CD86 and other adhesion molecules on leukemia and lymphoma cells and their induction by interferon
22. Chronic lymphocytic leukemia B cells can express CD40 ligand and demonstrate T-cell type costimulatory capacity
23. A functional role for interleukin (IL-)4-driven cyclic AMP accumulation in human B lymphocytes
24. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukemia cells
25. Regulation of interleukin-6 and interleukin-6R alpha (gp80) expression by murine immunoglobulin-secreting B cell hybridomas
26. Regulation of the assembly and expression of variable-region genes
27. The leukocyte-common antigen (CD45) complex and B-lymphocyte activation
28. The role of cell maturation in the generation of phenotypic heterogeneity in B-cell chronic lymphocytic leukemia
29. + B cells and helper T cells in immunoglobulin production
30. Human immunoglobulin (Ig)M+IgD+ peripheral blood cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells
31. + B cells
32. Frequent loss of the 11q14-24 region in chronic lymphocytic leukemia: A study by comparative genomic hybridization. Tampere CLL Group
33. Optimized mitogen stimulation induces proliferation of neoplastic B cells in chronic lymphocytic leukemia: Significance for cytogenetic analysis
34. Discontinuous deletions at 11q23 in B cell chronic lymphocytic leukemia
35. Frequent deletions at 11q23 and 13q14 in B cell prolymphocytic leukemia (B-PLL)
36. Distinct gene expression profiling in chronic lymphocytic leukemia with 11q23 deletion
37. CD79b expression in B cell chronic lymphocytic leukemia: Its implication for minimal residual disease detection
38. An alternatively spliced form of CD79b gene may account for altered B cell receptor expression in B-chronic lymphocytic leukemia
39. Complex chromosomal aberrations in chronic lymphocytic leukemia are associated with cellular drug and irradiation resistance